Machine learning identifies ac4C-related prognostic signature and TUBA1C as therapeutic target in COAD

Baizhi Zhai, Yuxiang Fan, Heng Ma, Xiaowei Xia, Yi Zhao, Jia Lu, Zhihong Zhang, Yi Wang, Bo Wu, Xia Yuan, Zhihui Yu · 2026

Read Machine learning identifies ac4C-related prognostic signature and TUBA1C as therapeutic target in COAD by Baizhi Zhai, Yuxiang Fan, Heng Ma, Xiaowei Xia, Yi Zhao, Jia Lu, Zhihong Zhang, Yi Wang, Bo Wu, Xia Yuan, Zhihui Yu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13541951.txt.

Description

Baizhi Zhai and co-authors built a risk signature for colon cancer in a 2026 study using machine learning. Their focus was genes linked to a chemical mark on RNA called ac4C. They aimed to find markers that predict outcome and point to treatment targets.

Data came from several public sets, including single-cell data, and ten learning methods were combined. A four-gene signature split patients into high and low risk groups with distinct survival, and it predicted outcome on its own. High-risk patients showed more genomic instability and a more suppressed immune setting. One gene stood out: blocking it in cells slowed growth and movement and raised cell death.

Catalog record

CREATORBaizhi Zhai, Yuxiang Fan, Heng Ma, Xiaowei Xia, Yi Zhao, Jia Lu, Zhihong Zhang, Yi Wang, Bo Wu, Xia Yuan, Zhihui Yu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13541951

Browse the full library · About the Tower of Babel